product_image_name-La Roche Posay-Anti-Imperfections Serum (30ml)-1

Share this product

La Roche Posay Anti-Imperfections Serum (30ml)

UGX 63,000

5 units left

+ shipping from UGX 1,900 to Central Business District
0 out of 5
(No ratings available)
Variation available

3offers starting fromUGX 63,000

See More Offers

Promotions

Delivery & Returns

Choose your location

Pickup Station

Delivery Fees UGX 1,900
Arriving at pickup station on 01 November When you order within the next 2hrs 59mins Ensure you pickup your order within 5 business days

Door Delivery

Delivery Fees UGX 3,000
Estimated delivery on 01 November When you order within the next 2hrs 59mins Our delivery agent will contact you on the day of delivery

Return Policy

Free return within 7 days for eligible items.Details

Seller Information

Chic And Charming

80%Seller Score

12 Followers

Follow

Seller Performance

Customer Rating: Good

OTHER SIMILAR OFFERS

UGX 63,000

Sold by: Kayz Beauty | Seller Score: 90%

Product details

La Roche-Posay Effaclar Serum is specifically formulated for adult acne-prone skin, targeting persistent imperfections, acne marks, and visible pores. This serum combines three exfoliating ingredients—salicylic acid, LHA, and glycolic acid—with soothing niacinamide to unclog pores and promote skin renewal. It effectively reduces blemishes and improves skin texture while being gentle enough for sensitive skin.

Specifications

Key Features

  • Salicylic Acid (1.5%): Unclogs pores and controls acne.
  • LHA (0.45%): Micro-exfoliates to refine skin texture.
  • Glycolic Acid (3.5%): Promotes skin renewal and reduces pigmentation.
  • Niacinamide (2%): Strengthens the skin barrier and reduces post-acne marks.
  • Non-Comedogenic: Suitable for oily and sensitive skin.

Specifications

  • SKU: LA508ST4WSKKINAFAMZ
  • Weight (kg): .9

Customer Feedback

This product has no ratings yet.

La Roche Posay Anti-Imperfections Serum (30ml)

La Roche Posay Anti-Imperfections Serum (30ml)

UGX 63,000
Questions about this product?

Recently Viewed

See All